Reactive oxygen species delay control of lymphocytic choriomeningitis virus

Cell Death and Differentiation

Volumn 20, Issue 4, 2013, Pages 649-658

  Lang, P A ^a,b,c   Xu, H C ^b,c,d   Grusdat, M ^c   McIlwain, D R ^b,c   Pandyra, A A ^d   Harris, I S ^b   Shaabani, N ^d   Honke, N ^d   Kumar Maney, S ^c   Lang, E ^d,e   Pozdeev, V I ^c   Recher, M ^a,f,g   Odermatt, B ^a   Brenner, D ^b,h   Haussinger D ^c   Ohashi, P S ^b   Hengartner, H ^a   Zinkernagel, R M ^a   Mak, T W ^b   Lang, K S ^a,c,d  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hepatitis; Liver cell damage; ROS; Virus

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GRANULOCYTE; IMMUNOPATHOLOGY; IN VITRO STUDY; LIVER CELL; LIVER INJURY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BUTHIONINE SULFOXIMINE; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLUTATHIONE; LIVER; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SPLEEN;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MURINAE; MUS;

EID: 84874948307     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.167     Document Type: Article

References (56)

1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-229.
2. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009; 119: 1745-1754.
3. From the Centers for Disease Control and Prevention. The global HIV and AIDS epidemic, 2001. JAMA 2001; 285: 3081-3083.
4. Sobao Y, Tomiyama H, Sugi K, Tokunaga M, Ueno T, Saito S et al. The role of hepatitis B virusspecific memory CD8 T cells in the control of viral replication. J Hepatol 2002; 36: 105-115.
5. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194: 1395-1406.
6. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181: 1047-1058.
7. Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145: 3442-3449.
8. Porichis F, Kaufmann DE. Role of PD-1 in HIV pathogenesis and as target for therapy. Curr HIV/AIDS Rep 2012; 9: 81-90.
9. Wherry EJ. T cell exhaustion. Nat Immunol 2011; 12: 492-499.
10. Kurokohchi K, Masaki T, Arima K, Miyauchi Y, Funaki T, Yoneyama H et al. CD28-negative CD8-positive cytotoxic T lymphocytes mediate hepatocellular damage in hepatitis C virus infection. J Clin Immunol 2003; 23: 518-527.
11. Leroy V, Vigan I, Mosnier JF, Dufeu-Duchesne T, Pernollet M, Zarski JP et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003; 38: 829-841.
12. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24: 759-765.
13. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994; 369: 31-37.
14. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.
15. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825-829.
16. Zinkernagel RM, Haenseler E, Leist T, Cerny A, Hengartner H, Althage A. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J Exp Med 1986; 164: 1075-1092.
17. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 2008; 14: 756-761.
18. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 2009; 41: 217-225.
19. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 2008; 10: 1343-1374.
20. Le Bras M, Clement MV, Pervaiz S, Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 2005; 20: 205-219.
21. Babior BM. NADPH oxidase: an update. Blood 1999; 93: 1464-1476.
22. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE 2006; 2006, re8.
23. Segal AW, Heyworth PG, Cockcroft S, Barrowman MM. Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44, 000 protein. Nature 1985; 316: 547-549.
24. Faust LR, el Benna J, Babior BM, Chanock SJ. The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis. J Clin Invest 1995; 96: 1499-1505.
25. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35: 297-306.
26. Wingler K, Hermans JJ, Schiffers P, Moens A, Paul M, Schmidt HH. NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol 2011; 164: 866-883.
27. Axelsen PH, Komatsu H, Murray IV. Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease. Physiology 2011; 26: 54-69.
28. Victor VM, Rocha M, Herance R, Hernandez-Mijares A. Oxidative stress and mitochondrial dysfunction in type 2 diabetes. Curr Pharm Des 2011; 17: 3947-3958.
29. Firestein GS. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. J Clin Invest 2004; 114: 471-474.
30. Dang PM, Stensballe A, Boussetta T, Raad H, Dewas C, Kroviarski Y et al. A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 2006; 116: 2033-2043.
31. Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, Mattsson R et al. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 2007; 117: 3020-3028.
32. Hultqvist M, Backlund J, Bauer K, Gelderman KA, Holmdahl R. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J Immunol 2007; 179: 1431-1437.
33. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003; 112: 1383-1394.
34. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122: 366-375.
35. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J Virol 2009; 83: 12934-12946.
36. Michalek RD, Pellom ST, Holbrook BC, Grayson JM. The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth. Virology 2008; 379: 205-212.
37. Lang PA, Recher M, Haussinger D, Lang KS. Genes determining the course of virus persistence in the liver: lessons from murine infection with lymphocytic choriomeningitis virus. Cell Physiol Biochem 2010; 26: 263-272.
38. Volpp BD, Nauseef WM, Donelson JE, Moser DR, Clark RA. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci USA 1989; 86: 7195-7199.
39. Jackson SH, Gallin JI, Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 1995; 182: 751-758.
40. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006; 10: 241-252.
41. Lang KS, Recher M, Navarini AA, Harris NL, Lohning M, Junt T et al. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol 2005; 35: 738-745.
42. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27: 670-684.
43. Purushothaman D, Sarin A. Cytokine-dependent regulation of NADPH oxidase activity and the consequences for activated T cell homeostasis. J Exp Med 2009; 206: 1515-1523.
44. Miyamoto Y, Koh YH, Park YS, Fujiwara N, Sakiyama H, Misonou Y et al. Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol Chem 2003; 384: 567-574.
45. D'Alessio M, Cerella C, Amici C, Pesce C, Coppola S, Fanelli C et al. Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells. FASEB J 2004; 18: 1609-1611.
46. Drew R, Miners JO. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochem Pharmacol 1984; 33: 2989-2994.
47. Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol 2010; 3: 314-320.
48. Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukocyte Biol 2008; 84: 949-957.
49. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579-591.
50. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 2008; 266: 37-52.
51. Welsh RM, Seedhom MO. Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage. Curr Protoc Microbiol 2008 Chapter 15: Unit 15A 1.
52. Battegay M, Cooper S, Althage A, Banziger J, Hengartner H, Zinkernagel RM. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods 1991; 33: 191-198.
53. Lang PA, Recher M, Honke N, Scheu S, Borkens S, Gailus N et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-Idependent manner in mice. Hepatology 2010; 52: 25-32.
54. Recher M, Lang KS, Navarini A, Hunziker L, Lang PA, Fink K et al. Extralymphatic virus sanctuaries as a consequence of potent T-cell activation. Nat Med 2007; 13: 1316-1323.
55. Lang PA, Cervantes-Barragan L, Verschoor A, Navarini AA, Recher M, Pellegrini M et al. Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood 2009; 113: 1045-1052.
56. McIlwain DR, Lang PA, Maretzky T, Hamada K, Ohishi K, Maney SK et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 2012; 335: 229-232.